Yervoy 5 mg Solution

    Yervoy 5 mg Solution

    S4


    1. What YERVOY is and what it is used for

    YERVOY contains the active substance ipilimumab, a protein which helps your immune system to attack and destroy cancer cells by your immune cells.

    YERVOY is used to treat advanced melanoma (a type of skin cancer) in adults.

    2. What you need to know before you use YERVOY

    YERVOY should not be administered to you:

    • if you are hypersensitive (allergic) to ipilimumab or any of the other ingredients of YERVOY (listed in section 6).

    Warnings and precautions

    Tell your doctor or healthcare provider before being given the injection: YERVOY may cause:

    • problems with your heart such as a change in the rhythm or rate of the heartbeat or an abnormal heart rhythm.
    • inflammation of the intestines (colitis) which can worsen to bleedings or bowel perforation. Signs and symptoms of colitis may include diarrhoea (watery, loose or soft stools), an increased number of bowel movements than usual, blood in your stools or darker-coloured stools, pain or tenderness in your stomach area.
    • problems with your lungs such as breathing difficulties or cough. These may be signs of inflammation of the lungs (pneumonitis or interstitial lung disease).
    • inflammation of the liver (hepatitis) that can lead to liver failure. Signs and symptoms of hepatitis may include eye or skin yellowing (jaundice), pain on the right side of your stomach area, tiredness.
    • inflammation of the skin that can lead to severe skin reaction (known as toxic epidermal necrolysis, Stevens-Johnson syndrome and Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)). Signs and symptoms of severe skin reaction may include skin rash with or without itching, peeling of the skin, dry skin, fever, fatigue, swelling of the face or lymph glands, increase of eosinophils (type of white blood cells) and effects on liver, kidneys or lungs. Please note that the reaction called DRESS may develop weeks or months after your last dose.
    • inflammation of the nerves that can lead to paralysis. Symptoms of nerve problems may include muscle weakness, numbness or tingling in your hands or feet, loss of consciousness or difficulty waking up.
    • inflammation or problems with your kidneys. Signs and symptoms may include abnormal kidney function tests, or decreased volume of urine.
    • inflammation of hormone producing glands (especially the pituitary, adrenal and thyroid glands) that may affect how these glands work. Signs and symptoms that your glands are not working properly may include headaches, blurry or double vision, tiredness, decreased sexual drive, behavioural changes, dizziness or lightheadedness, sweating, rapid heart rate, weight loss or weight gain.
    • Type 1 Diabetes, including diabetic ketoacidosis (acid in the blood produced from diabetes)
    • inflammation of the muscles such as myocarditis (inflammation of the heart muscle) and myositis (inflammation of the muscles). Signs and symptoms may include muscle pain, stiffness, weakness, chest pain, or severe fatigue.
    • inflammation of the eyes. Signs and symptoms may include redness in the eye, pain in the eye, vision problems, blurry vision or temporary loss of sight.
    • haemophagocytic lymphohistiocytosis (HLH). A rare disease in which our immune system makes too many of otherwise normal infection fighting cells called histiocytes and lymphocytes. Symptoms may include enlarged liver and/or spleen, skin rash, lymph node enlargement, breathing problems, easy bruising, kidney abnormalities, and heart problems.

    Tell your doctor immediately if you have any of these signs or symptoms or they get worse. Do not try to treat your symptoms with other medicines. Your doctor may give you other medicines in order to prevent more severe complications and reduce your symptoms, withhold the next dose of YERVOY, or stop your treatment with YERVOY altogether.

    Please note that these signs and symptoms are sometimes delayed and may develop weeks or months after your last dose. Before treatment, your doctor will check your general health. You will also have blood tests during treatment.

    Check with your doctor or healthcare professional before you are given YERVOY:

    • if you have an autoimmune disease (a condition where the body attacks its own cells)
    • if you have, or have ever had, chronic viral infection of the liver, including hepatitis B (HBV) or hepatitis C (HCV)
    • if you have human immunodeficiency virus (HIV) infection or acquired immune deficiency syndrome (AIDS)
    • if you have previously experienced a severe skin adverse reaction on a prior cancer therapy
    • if you have any history of inflammation of the lungs
    • if you have, or have ever had, tuberculosis
    • if you were treated for bladder cancer with immunotherapy called BCG

    Children and adolescents

    YERVOY should not be used in children below 18 years of age.

    Other medicines and YERVOY

    Always tell your healthcare provider if you are taking any other medicine. (This includes all complementary or traditional medicines.) Before you are given YERVOY, tell your doctor:

    • if you are taking any medicines that suppress your immune system, such as corticosteroids. These medicines may interfere with the effect of YERVOY. However, once you are treated with YERVOY, your doctor may give you corticosteroids to reduce the side effects that you may have with YERVOY.
    • if you are taking any medicines that stop your blood from clotting (anticoagulants). These medicines may increase the likelihood of bleeding in the stomach or intestine, which is a side effect of YERVOY.
    • if you have recently been prescribed vemurafenib, another medicine for the treatment of skin cancer). When YERVOY is given following prior vemurafenib there may be an increased risk of skin side-effects.

    Do not take any other medicines during your treatment without talking to your doctor first. Based on early data, the combination of YERVOY and vemurafenib is not recommended due to increased toxicity to the liver.

    Pregnancy and breastfeeding

    If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, please consult your doctor, pharmacist or other healthcare provider for advice before receiving YERVOY. Do not use YERVOY if you are pregnant. The active substance, ipilimumab, could harm an unborn baby.

    • You must use highly effective contraception while you are being treated with YERVOY if you are a woman who could become pregnant.
    • If you become pregnant while using YERVOY tell your doctor.
    • You should not breastfeed your baby when receiving YERVOY.

    Driving and using machines

    Do not drive, cycle or use machines after you have been given YERVOY unless you are sure you are feeling well. Feeling tired or weak is a very common side effect of YERVOY. This can affect your ability to drive, cycle or to use machines.

    YERVOY contains sodium Tell your doctor if you are on a low - sodium (low - salt) diet before you are given YERVOY. It contains 2,3 mg sodium per ml of concentrate.

    3. How to use YERVOY

    Do not share medicines prescribed for you with any other person.

    How YERVOY is given

    You will not be expected to give yourself YERVOY. It will be given to you by a person who is qualified to do so. YERVOY will be given to you in a hospital or clinic under the supervision of an experienced doctor. It will be given to you as an infusion (a drip) into a vein (intravenously) over a period of 90 minutes.

    How much YERVOY is given

    The recommended dose is 3 mg of ipilimumab per kilogram of your body weight. The amount of YERVOY you will be given will be calculated based on your body weight. Depending on your dose, some or all of the content of the YERVOY vial may be diluted with sodium chloride 9 mg/ml (0,9 %) solution for injection or 50 mg/ml (5 %) glucose solution for injection before use. More than one vial may be necessary to obtain the required dose. You will be treated with YERVOY once every 3 weeks, for a total of 4 doses. You may notice the appearance of new lesions or growth of existing lesions on your skin, which can be expected when you are being treated with YERVOY. Your doctor will continue giving you YERVOY for a total of 4 doses, depending on your tolerance to the treatment.

    If you receive more YERVOY than you should

    Since a healthcare professional will administer YERVOY, he/she will control the dosage. However, in the event of overdosage your doctor will manage the overdosage.

    If you miss a dose of YERVOY

    It is very important for you to keep all your appointments to receive YERVOY. If you miss an appointment, ask your doctor when to schedule your next dose.

    If you stop using YERVOY

    Stopping your treatment may stop the effect of YERVOY. Do not stop treatment with YERVOY unless you have discussed this with your doctor. If you have any further questions about your treatment or the use of YERVOY, ask your doctor.

    4. Possible side effects

    YERVOY can have side effects. Not all side effects reported for YERVOY are included in this leaflet. Should your general health worsen or if you experience any untoward effects while receiving YERVOY, please consult your doctor, pharmacist or other healthcare professional for advice. Be aware of important symptoms of inflammation. YERVOY acts on your immune system and may cause inflammation in parts of your body. Inflammation may cause serious damage to your body and some inflammatory conditions may be life-threatening. YERVOY can also cause hypersensitivity (allergic) reactions. Tell your doctor immediately if you get any of the following side effects.

    Do not try to treat your symptoms with other medicines. The following side effects have been reported in patients receiving YERVOY:

    Very common side effects

    • loss of appetite
    • diarrhoea (watery, loose or soft stools), vomiting or feeling sick (nausea), constipation, stomach pain
    • skin rash, itching
    • pain in the muscles, bones, ligaments, tendons, and nerves
    • feeling tired or weak, reaction at site of injection, fever, oedema (swelling), pain

    Common side effects

    • serious bacterial infection of the blood (sepsis), infection of the urinary tract, infection of the respiratory tract
    • tumour pain
    • A decreased number of red blood cells (which carry oxygen), white blood cells (which are important in fighting infection) or platelets (cells which help the blood to clot).
    • underactive function of the thyroid gland which can cause tiredness or weight gain, underactive function (hypopituitarism) or inflammation (hypophysitis) of the pituitary gland situated at the base of the brain
    • dehydration
    • confusion, depression
    • excessive accumulation of fluid in the brain, damage to the nerves (causing pain, weakness and cramps), dizziness, headache
    • blurred vision, pain in the eye
    • irregular of abnormal heartbeat
    • low blood pressure, temporary redness of the face and neck, feeling of intense heat with sweating and rapid heartbeat
    • shortness of breath (dyspnoea), cough, hay fever
    • bleeding in the stomach or intestine, inflammation of the intestines (colitis), heartburn, mouth ulcers and cold sores (stomatitis)
    • abnormal function of the liver
    • inflammation of the inner surface lining of a particular organ
    • inflammation and redness of the skin, skin colour change in patches (vitiligo), hives (itchy, bumpy rash), hair loss or thinning, excessive sweating at night, dry skin
    • pain in muscles and joints (arthralgia), muscle spasms, inflammation of the joints (arthritis)
    • kidney function failure
    • shivering, lack of energy
    • flu-like illness
    • decrease in body weight

    Uncommon side effects:

    • serious bacterial infection of the blood (septic shock), inflammation around the brain or spinal cord, inflammation of the stomach and intestines, inflammation of bowel wall (causing fever, vomiting and stomach pain), lung infection
    • a group of symptoms due to cancer in the body such as high blood levels of calcium and cholesterol, and low blood levels of sugar (paraneoplastic syndrome)
    • increase of eosinophils (type of white blood cells)
    • allergic reaction

    Changes in test results

    YERVOY may cause changes in the results of tests carried out by your doctor. These include:

    • a variation in the number of red blood cells (which carry oxygen), white blood cells (which are important in fighting infection) or platelets (cells which help the blood to clot)
    • an abnormal variation of hormones and liver enzyme levels in the blood
    • abnormal liver function test
    • abnormal levels of calcium, sodium, phosphate or potassium in the blood
    • presence of blood or proteins in the urine
    • an abnormally high alkalinity of the blood and other body tissues
    • kidneys unable to remove acids from blood normally
    • presence of antibodies in the blood against some of your own cells

    If you notice any side effects not mentioned in this leaflet, please inform your doctor or pharmacist.

    Reporting of side effects

    If you get side effects, talk to your doctor, pharmacist or nurse. You can also report side effects to SAHPRA via the Med Safety APP (Medsafety X SAHPRA) and eReporting platform (who-umc.org) found on SAHPRA website. By reporting side effects, you can help provide more information on the safety of YERVOY.

    5. How to store YERVOY

    Store all medicines out of reach of children.

    Store in a refrigerator (2 °C – 8 °C).

    Store in the original package in order to protect from light. Do not freeze.

    For single use only. Discard any unused portion. Once opened, the product should be infused or diluted and infused immediately. The chemical and physical in-use stability of the undiluted or diluted concentrate (between 1 mg/ml and 4 mg/ml) has been demonstrated for 24 hours at 25 °C and 2 °C to 8 °C. If not used immediately, the infusion solution (undiluted or diluted) may be stored for up to 24 hours either under refrigeration (2 °C to 8 °C) or at room temperature (25 °C).

    Do not use YERVOY after the expiry date which is stated on the carton and the vial label after EXP. The expiry date refers to the last day of that month.

    Important Disclaimer

    The Yervoy 5 mg Solution professional information leaflet below is the property of Equity Pharmaceutical and is provided on Somayeza exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Somayeza serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

    Unlock Exclusive Features

    To ensure the fastest, most secure experience, this feature is exclusively available on the free Somayeza mobile app.

    Download the App to Unlock
    On This Page
    Yervoy 5 mg Solution
    1/-
    Official PDF leaflet

    The patient information text is available above. Load the original PDF only when you need it.

    Somayeza AI
    Hello! I am your medical reading assistant. What would you like to know about this patient information leaflet?
    Successfully Stashed! 💊

    This patient information leaflet has been safely stored in your digital medical cabinet. No prescription needed to view it later!

    View My Favourites